Epidemiology of Sjögren syndrome

被引:37
|
作者
Beydon, Maxime [1 ]
McCoy, Sara [2 ]
Nguyen, Yann [1 ,3 ]
Sumida, Takayuki [4 ]
Mariette, Xavier [1 ,3 ]
Seror, Raphaele [1 ,3 ]
机构
[1] Univ Paris Saclay, Bicetre AP HP Hop, Dept Rheumatol, Paris, France
[2] Univ Wisconsin Madison, Dept Med, Madison, WI USA
[3] Univ Paris Saclay, Ctr Immunol Viral Infect & Autoimmune Dis, INSERM U1184, Le Kremlin Bicetre, France
[4] Univ Tsukuba, Dept Internal Med, Tsukuba, Japan
关键词
PRIMARY SJOGRENS-SYNDROME; SYSTEMIC-LUPUS-ERYTHEMATOSUS; NON-HODGKIN-LYMPHOMA; QUALITY-OF-LIFE; AUTOIMMUNE RHEUMATIC-DISEASES; CLASSIFICATION CRITERIA; SICCA SYMPTOMS; CLINICAL CHARACTERISTICS; FOLLOW-UP; INTERNATIONAL-CLASSIFICATION;
D O I
10.1038/s41584-023-01057-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Sjogren syndrome is a phenotypically varied autoimmune disorder that can occur alone in primary Sjogren syndrome or in association with other connective tissue diseases (CTDs), including rheumatoid arthritis, systemic lupus erythematosus (SLE) and systemic sclerosis (SSc). The estimation of the prevalence and incidence of Sjogren syndrome varies depending on diagnostic criteria and study design, making it difficult to estimate geographical and temporal trends. Nonetheless, disease phenotype is influenced by geographical origin, which is a risk factor for systemic activity. Whether mortality in primary Sjogren syndrome is increased compared with that of the general population is not yet known, but extra-glandular manifestations, in particular lymphomas, are clear risk factors for mortality. In CTDs associated with Sjogren syndrome, lymphoma risk seems higher than that of patients with CTD alone, and there is potentially lower disease activity in SLE with Sjogren syndrome and in SSc with Sjogren syndrome than in SLE or SSc alone. In this epidemiological Review, the authors summarize the available evidence relating to the prevalence, incidence, risk factors and mortality associated with the autoimmune disorder Sjogren syndrome, with or without the co-occurrence of other connective tissue diseases. Primary Sjogren syndrome (pSS) affects mostly women, with age at disease onset as well as systemic activity varying according to geographical origin.Assessment of the prevalence of pSS varies according to study methodology, but can be estimated at between 0.01% and 0.05%, although some countries might be under-represented in this estimation.Mortality in pSS seems to be elevated predominantly in patients with extra-glandular manifestations, pulmonary involvement and non-Hodgkin lymphoma.pSS is the autoimmune disease with the most important increased risk of non-Hodgkin lymphoma, especially among patients with extra-glandular manifestations or systemic activity, low complement levels, cryoglobulinaemic vasculitis or rheumatoid factor positivity.Sjogren syndrome can be associated with other connective tissue diseases, mainly rheumatoid arthritis, systemic lupus erythematosus and systemic sclerosis.
引用
收藏
页码:158 / 169
页数:12
相关论文
共 50 条
  • [1] Epidemiology of Sjögren's: A Systematic Literature Review
    Thurtle, Eleanor
    Grosjean, Alice
    Steenackers, Monia
    Strege, Katharina
    Barcelos, Giovanna
    Goswami, Pushpendra
    RHEUMATOLOGY AND THERAPY, 2024, 11 (01) : 1 - 17
  • [2] Investigative biological therapies for primary Sjögren's syndrome
    He, Shi-Hao
    Xuan, Yi-Yi
    Liang, Xu
    Guo, Kuang-Jin
    Wang, Yan
    Fu, Xiao-Ning
    Li, Tian-Fang
    ARCHIVES OF MEDICAL SCIENCE, 2024, 20 (02) : 506 - 516
  • [3] Update on the pathophysiology and treatment of primary Sjögren syndrome
    Baldini, Chiara
    Fulvio, Giovanni
    La Rocca, Gaetano
    Ferro, Francesco
    NATURE REVIEWS RHEUMATOLOGY, 2024, 20 (08) : 473 - 491
  • [4] Update on Sjögren's Syndrome: Diagnostics & Therapy
    Zehrfeld, Nadine
    Witte, Torsten
    Ernst, Diana
    AKTUELLE RHEUMATOLOGIE, 2024, 49 (03) : 168 - 177
  • [5] Operational characteristics of ultrasound in the diagnosis of Sjögren's syndrome
    Guavita-Navarro, D.
    Ibanez, C.
    Cajamarca-Baron, J.
    Rodriguez, D. E. Avendano
    Torres-Castiblanco, J. L.
    Barahona, A. B. Villamizar
    Burbano, H. D. Burbano
    Trujillo, A. Escobar
    Polo, J. F.
    Rojas-Villarraga, A.
    RADIOLOGIA, 2024, 66 (01): : 13 - 22
  • [6] The spectrum and prognosis of Sjögren's syndrome with membranous nephropathy
    Qiu, Dan-dan
    Li, Zhi
    Wang, Jing-jing
    Chen, Du-qun
    Tu, Yuan-mao
    Liang, Shao-shan
    Xu, Feng
    Liang, Dan-dan
    Zhang, Ti
    Cheng, Zhen
    CLINICAL KIDNEY JOURNAL, 2025, 18 (02)
  • [7] Epidemiology of cutaneous involvement in Sjögren syndrome: Data from three French pSS populations (TEARS, ASSESS, diapSS)
    Villon, Camille
    Orgeolet, Laure
    Roguedas, Anne-Marie
    Misery, Laurent
    Gottenberg, Jacques-Eric
    Cornec, Divi
    Jousse-Joulin, Sandrine
    Seror, Raphaele
    Berthelot, Jean-Marie
    Dieude, Philippe
    Dubost, Jean-Jacques
    Fauchais, Anne-Laure
    Goeb, Vincent
    Hachulla, Eric
    Hatron, Pierre-Yves
    Larroche, Claire
    Hayem, Gilles
    Le Guern, Veronique
    Perdriger, Aleth
    Morel, Jacques
    Vittecoq, Olivier
    Mariette, Xavier
    Devauchelle-Pensec, Valerie
    Saraux, Alain
    JOINT BONE SPINE, 2021, 88 (04)
  • [8] Seronegative Sjögren Syndrome: A Forgotten Entity?
    Lee, Adrian Y. S.
    Rischmueller, Maureen
    Reed, Joanne H.
    JOURNAL OF RHEUMATOLOGY, 2024, 51 (01) : 7 - 9
  • [9] A single-center study of clinical features of pediatric Sjögren's syndrome
    Hou, Ling
    Wang, Ningning
    Zhao, Chengguang
    Wang, Xiuli
    Du, Yue
    PEDIATRIC RHEUMATOLOGY, 2023, 21 (01)
  • [10] Application of omics in Sjögren's syndrome
    He, Wenqin
    Lu, Yangyang
    Shi, Rongjing
    An, Qi
    Zhao, Jingwen
    Gao, Xinnan
    Zhang, Liyun
    Ma, Dan
    INFLAMMATION RESEARCH, 2023, 72 (12) : 2089 - 2109